Mark Frasier, PhD
Senior Vice President, Research Programs
Michael J. Fox Foundation for Parkinson's Research
Mark Frasier, PhD, joined the Foundation in March 2006. Dr. Frasier received his BS in Biochemistry from the University of Dayton and his PhD in pharmacology from Loyola University Chicago. His dissertation was completed in the laboratory of Benjamin Wolozin and focused on understanding the biological function of proteins implicated in neurodegeneration such as alpha-synuclein and tau. Dr. Frasier completed his postdoctoral work in the Neuroscience Discovery Research Group at Eli Lilly, Inc., in Indianapolis, Indiana, where he worked on drug-discovery research in Parkinson’s and Alzheimer’s disease.